Johannah Moncecchi
About Johannah Moncecchi
Johannah Moncecchi is a Scientist III at Alkermes in Dublin, Ireland, with a background in organic chemistry and extensive experience in medicinal and process chemistry.
Current Role at Alkermes
Johannah Moncecchi currently holds the position of Scientist III at Alkermes plc, located in Dublin, Ireland. She has been with the company since July 2016. In her role, she focuses on developing innovative medicines primarily for central nervous system (CNS) diseases. Her work involves leveraging her expertise to deliver high-quality intermediates and active pharmaceutical ingredients (APIs).
Previous Experience at Johnson Matthey Fine Chemicals
Before joining Alkermes, Johannah worked at Johnson Matthey Fine Chemicals in the United States from 2014 to 2016. During her two years as a Staff Chemist, she gained significant experience in the field, contributing to various projects and enhancing her skills in delivering high-quality chemical intermediates.
Work Experience at Merck
Johannah Moncecchi accumulated valuable experience at Merck, where she served in multiple roles. From 2009 to 2013, she worked as a Scientist in Kenilworth, New Jersey, for four years, focusing on medicinal and process chemistry efforts. Prior to that, she was an Assistant Scientist for five months in 2009, also in Kenilworth, New Jersey. These roles helped her develop a robust skill set in the pharmaceutical industry.
Educational Background and Specialization
Johannah Moncecchi pursued her higher education in the field of chemistry. She earned her Master of Science in Organic Chemistry from Colorado State University, where she studied from 2006 to 2009. Before that, she completed her Bachelor of Science in Chemistry from the University of Wyoming, attending from 2001 to 2006. Her academic background provided her with a strong foundation for her career in the chemical and pharmaceutical industries.
Expertise in Biocatalytic Techniques
Johannah Moncecchi has specialized expertise in biocatalytic techniques for the preparation of chiral building blocks. This niche skill has been instrumental in her various roles throughout her career, enabling her to contribute significantly to projects involving complex chemical processes and the development of pharmaceutical compounds.